−0.23), this difference did not reach statistical significance and was not sustained at Week 24, at which point both arms showed comparable declines.
← all excerpts
Patient-reported outcomes in castration-resistant prostate cancer with bone metastases treated with radium-223 with or without olaparib.
1
—
—